Renaissance Technologies
MBII

Renaissance Technologies’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Renaissance Technologies’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-59,600
Closed -$43K – 4619
2021
Q4 		$43K Sell
59,600
-235,900
-80% -$191K ﹤0.01% 3796
2021
Q3 		$266K Buy
295,500
+274,100
+1,281% +$330K ﹤0.01% 3120
2021
Q2 		$36K Buy
+21,400
New +$35.8K ﹤0.01% 3400
2021
Q1 		– Sell
-113,191
Closed -$141K – 3855
2020
Q4 		$141K Buy
113,191
+71,191
+170% +$84.9K ﹤0.01% 3212
2020
Q3 		$51K Buy
+42,000
New +$51.1K ﹤0.01% 3272
2015
Q3 		– Sell
-22,887
Closed -$45K – 3438
2015
Q2 		$45K Buy
+22,887
New +$64.9K ﹤0.01% 3165

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies's MBII Position: Q1 2022 in Review

Renaissance Technologies sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 59,600 shares — an estimated $43K sold.

Renaissance Technologies first reported a position in MBII in Q2 2015 and held it in 6 quarters. The position peaked at $266K in Q3 2021. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • Renaissance Technologies reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • Renaissance Technologies sold 59,600 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $43K.
  • Renaissance Technologies first reported a position in Marrone Bio Innovations, Inc. in Q2 2015 and held it in 6 quarters.
  • Renaissance Technologies's Marrone Bio Innovations, Inc. position peaked at $266K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.